Propentofylline
Chemical compound
From Wikipedia, the free encyclopedia
Propentofylline (HWA 285) is a xanthine derivative drug with purported neuroprotective effects.
| |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.133.568 |
| Chemical and physical data | |
| Formula | C15H22N4O3 |
| Molar mass | 306.366 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Pharmacology
It is a phosphodiesterase inhibitor,[1] and also acts as an adenosine reuptake inhibitor.[1][2][3]
Uses
Propentofylline was studied as a possible treatment for Alzheimer's disease and multi-infarct dementia,[1][4] and has been studied, to a lesser extent, as a possible adjunct in the treatment of ischemic stroke, due to its vasodilating properties.[5][6]
Propentofylline is in use as a veterinary medicine in older dogs.[7]